On May 28, 2019, Beike Biotech and Shenzhen Third People’s Hospital jointly held a signing ceremony for strategic cooperation in cell therapy and clinical research. Liu Lei, President of Shenzhen Third People’s Hospital, Hu Xiang, Chairman of Shenzhen Beike Biotechnology Co., Ltd., and many other leaders and guests attended the signing ceremony.
According to the agreement, the two parties will cooperate to carry out stem cell clinical research base and stem cell clinical research project registration. After the registration is successful, clinical research on stem cells in the field of liver disease treatment will be carried out at Shenzhen Third People’s Hospital. This clinical research is expected to obtain safety and effectiveness data of stem cells in the treatment of acute and chronic liver diseases, and provide standardized clinical solutions for stem cell treatment of such liver diseases.